Position in RNA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$448,154
New position
Shares Held
33,320
first reported quarter
Ownership
0.195%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 153 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Moran Wealth Management, LLC holds $37,590,704 across 10 Biotechnology names. RNA ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
186,672 | $10,466,698 | |
| 2 | EXEL |
Exelixis, Inc.
|
141,150 | $7,679,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
80,381 | $6,291,420 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
19,790 | $6,255,420 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,300 | $2,681,221 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
35,374 | $1,929,297 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
47,977 | $1,569,807 | |
| 8 | RNA |
Atrium Therapeutics, Inc.
This page
|
33,320 | $448,154 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $448,154 | 33,320 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||